AIM:NYSEAMERICAN
AIM ImmunoTech Inc
$0.23
arrow_downward
-2.61%(-0.0061) 1D
$0.23
arrow_upward
+1.23% (+0.0028)bedtimeAfter hours
Closed: Sep 4, 4:00:00โฏPM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AIM...
Open
$0.23
High
$0.24
Low
$0.23
Mkt. cap
7.04M
Avg. vol.
7.60M
Volume
9.32M
52-wk high
$2.98
52-wk low
$0.19
EPS
-$3.93
Beta
1.19
Shares outstanding
30.44M
No. of employees
20
Open
$0.23
High
$0.24
Low
$0.23
Mkt. cap
7.04M
Avg. vol.
7.60M
Volume
9.32M
52-wk high
$2.98
52-wk low
$0.19
EPS
-$3.93
Beta
1.19
Shares outstanding
30.44M
No. of employees
20
News stories
From web sources and news partners
Minichart
·
1 day ago
AIM ImmunoTech Eliminates $1.22 Million Debt via Stock Exchange
Profile
AIM ImmunoTech Inc., formerly known as Hemispherx Biopharma Inc., is a biopharmaceutical company based in Ocala, Florida that is focused on the research and development of therapeutics to treat multiple types of cancers, various viruses and immune-deficiency disorders. Founded in 1990, the company has twenty-three employees.
The company has created an immunomodulatory double stranded RNA drug called Ampligen.
It is also developing Ampligen to use as a treatment for multiple cancer tumor types, COVID-19 and chronic fatigue syndrome. Wikipedia
About AIM ImmunoTech Inc
CEO-
Employees20
Founded1966
HeadquartersPhiladelphia, Pennsylvania, United States
SectorBiotechnology
Websiteaimimmuno.com